Early Lapatinib-Induced Skin Rash Predicts Better Survival With

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

Molecular Heterogeneity and Response to Neoadjuvant Human

Pharmaceutics, Free Full-Text

Recommendations on management of EGFR inhibitor-induced skin

Clinical management of cutaneous adverse events in patients on

Lapatinib with trastuzumab for HER2-positive early breast cancer

Lapatinib as first-line treatment for muscle-invasive urothelial

Lapatinib in Breast Cancer

PDF) Lapatinib and lapatinib plus trastuzumab therapy versus

Erlotinib-Induced Skin Rash. Pathogenesis, Clinical Significance